A rodent platform entirely dedicated to innovation in experimental psychopathology 

Resources

OptoPath has been granted 6 000 000 euros over 9 years in the context of the Investissements d’Avenir (Investment for the future) plan of the French government).



Beside equipment, Optopath was granted 1 800 000 euros by Inserm * for the construction of a dedicated building in the premises of the Neurocentre Magendie

Inserm *: Institut National de la Santé et de la Recherche Médicale – National Institute of Health and Medical Research 



TOP